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Background: Trans-anal endoscopic operation (TEO) has developed to facilitate proper tumor location
and ensure excision safely.
Methods: We reviewed 92 patients enrolled in our database between 2006 and 2014 who were diag-
nosed with early rectal tumors and who underwent conventional trans-anal excision (TAE) or TEO.
Clinical data were collected prospectively to compare safety and feasibility between two techniques.
Results: Ninety-two patients underwent trans-anal local excision for lower rectal tumors. TEO and TAE
were performed in 48 and 44 patients, respectively. Age, sex, and comorbidities were similar. There was
no signiﬁcant difference in tumor diameter (1.6 ± 1.68 cm vs. 1.17 ± 1.17, respectively). Tumor height,
however, was higher in the TEO (7.46 ± 3 cm) than the TAE group (3.84 ± 1.88 cm, p < 0.001). Four
complications, perianal abscess, and two perforations, occurred in the TEO group, whereas no major
complications occurred in the TAE. Seven patients (14.6%) underwent TEO underwent a salvage operation
compared to only a single patient in TAE group (2.3%, p ¼ 0.039). Eight patients (17.4%) diagnosed with
adenocarcinoma developed recurrence, four in each group. Disease-free survival was similar between
groups (TEO e 41.8 months, 95% RI 39.4e44.1; TAE 79.7 months, 95% RI 72.2e87.3). However, more TAE
patients (n ¼ 7, 15.9%) than TEO patients (n ¼ 2, 4.2%) underwent chemotherapy.
Conclusions: TEO treatment of local rectal tumors is safe and feasible and can achieve an adequate
resection margin. Local recurrence was similar in both groups. However, the numbers of salvage oper-
ations and minor complications were higher in the TEO group.
© 2017 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).ivision of Colorectal Surgery,
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Total mesorectal excision (TME) is considered the standard
procedure of care in rectal cancer; however, morbidity, sexual
urinary dysfunction, and stoma complication rates are at high
rate [1,2]. Radical resection is therefore indicated for tumors
invading the submucosa layer. Trans-anal excision (TAE) is per-
formed for early rectal cancer or accessible low rectal benign
tumors to avoid unnecessary major surgery or postoperativeGroup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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that the rates of non-TME, local resection for stage I rectal cancer
increased between 1998 and 2010: for T1 cancers, rates increased
from 39.8% to 62%, and for T2 cancers, from 12.2 to 21.4% in 2007.
You et al. [4] reported a rise in local excision rate and a near
tripled risk of local recurrence following local therapy compared
with radical surgery.
Methods to localize and visualize the lesion in the setting of
an anal endoscopic operation (TEO) as well as trans-anal endo-
scopic microsurgery (TEM) have beneﬁtted from recent techno-
logical advances. These modern techniques are well established
and offer a stable operating platform with magniﬁed stereoscopic
view for precise full-thickness excision of the rectal wall as far as
15e20 cm from the anal verge [5]. However, TEO is inappropriate
for deeper tumors; the TEO procedure was developed for local
treatment of early rectal tumor. Lymphadenectomy is not ach-
ieved when there is a risk of lymph node metastasis. Mesenteric
nodal positivity is approximately 10e13% in T1 cancers and
17e22% in T2 cancers [6,7]. Accurate preoperative tumor and
nodal staging are therefore both necessary for correct procedure
selection.
For T1 cancers, deep invasion into the submucosal layer is a
predictor of nodal positivity [8]. Local excision is considered an
inferior approach to radical resection because of higher local
recurrence rates and lower overall survival [9,10]. T1 cancers that
have not metastasized to mesorectal lymph nodes can be appro-
priately treated with local excision as long as adequate margins are
obtained. Therefore, the most critical aspect in treating T1 rectal
cancers with local excision is to identify low risk tumors with
superfascial submucosa invasion. If one-third of the submucosa is
invaded (SM1) or two-thirds of the submucosa is invaded (SM2), a
low risk of lymph node metastases is assumed, and local excision
can be performed if technically feasible [11].
National Comprehensive Cancer Network (NCCN) guidelines
[12] suggest that well-to moderately-differentiated T1 cancers
less than 3 cm in size that occupy less than 30% of the circum-
ference and that show no evidence of lymphovascular invasion
are suitable for local excision. However, with technological ad-
vances in the TEO procedure, indications for trans-anal excision
have been modiﬁed to include larger and higher level tumors. In
addition, TEO and TEM techniques result in fewer fragmented
specimens and fewer positive margins than TAE [13]. Memorial
Sloan-Kettering Cancer Center reported local recurrence rates of
13.2% for TAE versus 2.7% for TME [14]. In this study, we
compared the recurrence and disease-free survival rate of pa-
tients with rectal tumors who underwent conventional TEO or
the TAE procedure.
2. Methods
2.1. Patients
The study protocol was reviewed and approved by our hospital's
Institutional Review Board. This study is a retrospective study. A
prospectively maintained database was used to identify all patients
who underwent TEO and TAE for rectal tumors from 2006 to
December 2014. Surgery was performed at Severance Hospital,
Yonsei University College of Medicine in Seoul, Republic of Korea.
Ninety-two consecutive patients aged 18 years or older with rectal
tumors (within 15 cm of the anal verge) provided consent for
enrollment in the study. All rectal cancers were staged according to
the guidelines of the American Joint Committee of Cancer. We
excluded patients who were unﬁt for surgery, those with an ASA
score of III-IV, a tumor deeper than T1 sm2, or those not willing to
undergo minimally invasive surgery.2.2. Inclusion criteria
The indications for transanal excisionwere T1 adenocarcinomas
with a superﬁcial depth estimated by endorectal ultrasound
(ERU), adenomas, carcinoid tumors <2 cm, and other submu-
cosal tumors, as well as re-excision of a positive resection
margin after endoscopic resection. Palliative local excision of
rectal adenocarcinoma after preoperative chemoradiotherapy
advocated in older patients, those unﬁt for major surgery, and
those who refused radical rectal resection. Transanal excision
also performed in those patients showing good response after
chemotherapy to the level of no residual tumor. Thus, transanal
excision performed to rule out any residual disease. In addition,
tumors between 3 and 15 cm from the anal verge were
considered for local excision procedures. All tumors <75% of
rectal wall circumference and at any position were indicated for
TEO. Those Patients who had a higher tumor location >15 cm
from anal verge, T2 lesion or presence of distantmetastasis were
excluded from our study. Whether TEO or TAE performed is all
based on surgeon preference.2.3. Tumor diagnosis and follow-up
All patients underwent preoperative evaluation including his-
tory taking, digital rectal examination, routine laboratory tests,
chest radiography, endorectal ultrasound (ERU), and colonoscopy
with biopsy. For suspected cancers that were biopsied, proper
staging for systemic disease was requested. The level of serum
carcinoembryonic antigen, chest X-ray, computed tomographic
scan, and/or magnetic resonance imaging were performed if
needed. The treatment strategy for all patients was discussed at a
multidisciplinary team meeting. All patients underwent bowel
preparation before surgery and received a single prophylactic dose
of antibiotics 30min before anesthesia induction or at skin incision.
The ﬁve senior professors whowere involved in this study had each
performed in excess of 200 colorectal cancer resections. Post-
operatively, patients were monitored for a few days and discharged
as soon as they tolerate food orally and pass ﬂatus without com-
plications. Two weeks after discharge, patients visited the outpa-
tient clinic for follow-up. Adjuvant chemotherapy (5-Flurouracil
and lecuvorine) is prescribed if tumor has showing malignant
feature in the ﬁnal histopathology. Radical surgery is advocated if
tumor depth inﬁltrating through the last third of submucosa.
Chemo-radiotherapy regimen composite of radiation therapy at a
dose of 45 Gy (25  1.8 Gy) along with daily dose of 1650 mg/m2
capecitabine was administered orally, divided into two equal doses
per day.
2.4. Statistical analysis
Data are summarized as frequencies and percentages for cate-
gorical variables. Medians and ranges are used for continuous
variables. Chi-squared tests were used to compare proportions, and
the independent t-test was performed for comparison of contin-
uous variables. Univariate analysis of OS and DFS was carried out by
the Kaplan-Meier method. Results were considered statistically
signiﬁcant if the p value was less than 0.05. Statistical Package for
the Social Sciences for Windows (Version 20.0, Chicago, IL) was
used for data analyses. Disease-free survival was deﬁned as the
time from surgery to any recurrence documented during follow-up.
Postoperative complications were deﬁned as any adverse events
occurring within 30 days. Recurrence was identiﬁed if any mass or
nodule was observed in imaging studies during follow-up. Con-
version was deﬁned as the need to convert from a minimally
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staywas deﬁned as the number of nights the patient spent from the
day of surgery until discharge. All tumor inﬁltration through sub-
mucosa only are considered T1 lesion. Tumor level was deﬁned as
the distance from the inferiormargin of the tumor to the anal verge.
2.5. Trans-anal endoscopic operation technique
All patients underwent transanal local excision by either the
conventional method or by a modern and minimum invasive
technique installed in the TEO system (Karl Storz Endoscopy, Tut-
tlingen, Germany). The newer technique was performed as follows.
General anesthesia was inducted in all patients. The patient was
positioned in the lithotomy position regardless of tumor location
(anterior, posterior, or lateral). Digital rectal exam and rigid
sigmoidoscopy were performed in the operating room to conﬁrm
tumor location. Local anesthetic was injected circumferentially at
the submucosa to facilitate surgical dissection. A TEO system was
installed and ﬁxed at the side of the operating table. A rectoscope
was inserted into the rectum at the tumor level with appropriate
selection of rectoscope size (7.5 or 15 cm long, 4 cm in diameter).
The working attachment used with the rectoscope had three
channels: two for 5-mm-diameter instruments (30-degree angled
camera and grasper) and one channel for instruments up to 12 mm
(see Fig. 1). In addition, there were two CO2 channels for insufﬂa-
tion, smoke evacuation, and irrigation. The operating ﬁeld was
visualized through a monitor connected to the system.
Distal and proximal margins were obtained by marking at least
0.5e1 cm circumferentially around the tumor. The dissection plane
deepened into the muscle layer approaching the perirectal fat for
full-thickness excision to achieve an adequate circumferential
resection margin (CRM) (Fig. 2). The excised specimen was aligned
well by a pin needle for a pathologist to recognize the exact tumor
margin. Rectal wall defects were irrigated with normal saline and
closed by interrupted absorbable sutures supported by a knotFig. 1. TEO System Installed on the Side of the Operating Table. Trans-anal scope channel w
dissection.pusher (Karl Storz Endoscopy) or continuous V-Loc sutures (Covi-
dien). Procedure details are visualized in Fig. 2.
3. Results
3.1. Patients and tumor characteristics
From January 2006 to December 2014, 92 patients underwent
trans-anal excision at our institute. Of these, 48 patients underwent
TEO, whereas 44 patients underwent TAE. Median age of the TEO
and TAE groups was 58 and 62 year, (p ¼ 0.39), respectively. The
majority of patients were male in both groups 32 (66.7%) in the TEO
group and 23 (51.1%) in the TAE group (p ¼ 0.16)]. Adenocarcinoma
was the most common rectal tumor, with an incidence of 15 (31.2%)
in the TEO group and 22 (50%) in the TAE group (p ¼ 0.239). Ade-
noma, neuroendocrine tumor (NET), gastro-intestinal stromal tis-
sue (GIST), and melanoma were the other tumor types. Trans-anal
excision was performed because of a positive margin after endo-
scopic mucosal resection (EMR) in 16 (33.3%) subjects in the TEO
group and ﬁve (11.4%), (p ¼ 0.673) in the TAE group. In addition,
patient also underwent surgery if they responded well to chemo-
radiotherapy and were down-staged to the level of no clinical ev-
idence of cancer. In these patients, trans-anal excision was
performed to rule out any residual cancer; this was carried out by
TEO in two patients (4.2%) and TAE in seven patients (15.9%),
(p ¼ 0.10). Patient characteristics are detailed in Table 1.
3.2. Pathology outcomes
Mean tumor size was similar between the TEO and TAE groups
at 1.6 ± 1.68 cm and 1.17 ± 1.17 cm, respectively (p ¼ 0.148). Final
histopathology diagnosed adenocarcinoma in 16 (33.3%) vs. 20
(45.5%) patients in the TEO versus TAE groups, (p ¼ 0.082), while
adenoma was reported in seven TEO patients (14.6%) vs. six TAE
patients (13.6%), NET in 24 TEO patients (50%) vs. 13 TEO patientsith three entries, one for the camera and two for TEO instruments, to facilitate tumor
Fig. 2. TEO Procedure from Early Tumor Identiﬁcation to Defect Closure. A: Polypoid mass in the lower rectum, B: Procedure starts with circumferential resection all around the
tumor, C: Complete excision of the tumor, D: Closure of the defect, E: Alignment of the tumor on a brush ship using a needle pin to determine the resection margin.
Table 2
Comparison of pathological outcomes between TEO and TAE.
Parameters TEO (n ¼ 48) TAE (n ¼ 44) P-value
Margin invasion 0.339
No 44 (93.6%) 43 (100%)
Yes 3 (6.4%) 1 (2.3%)
LVI 0.320
No 45 (93.8%) 43 (100%)
Yes 3 (6.2%) 0 (0%)
AV (mean, cm) 7.46 ± 3 3.84 ± 1.88 <0.001
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TAE patients (6.8%) (p ¼ 0.239), respectively. For the adenocarci-
nomas, tumor depth (T stage) was T1 submucosa 1 (sm1) in 6
(37.5%) TAE vs. 7 (35%) TEO patients, sm2 in two TEO (12.5%) vs.
three (15%) TAE patients, and T1SM3 in two (12.5%) TEO vs. three
(15%) TAE patients. Tumor depth was T2 in three (18.8%) TEO pa-
tients vs. two (10%) TAE patients and T3 in one (6.2%) TEO vs. 0 (0%)
TAE patients (p¼ 0.082). Interestingly, tumors located higher in the
TEO group had a mean distance from the anal verge of 7.46 ± 3 cm
compared to 3.84 ± 1.88 cm in the TAE group (p < 0.001). Positive
tumor resection margin and the presence of lympho-vascular in-
vasion were similar in the TEO and TAE groups 3 (6.4%) vs. 1 (2.3%),
(p ¼ 0.339) for positive tumor resection margin and 3 (6.2%) vs.
0 (0%), (p ¼ 0.320) for the presence of lympho-vascular invasion,
respectively. Histopathology results are presented in Table 2.
3.3. Complications and treatment differences
Surgical conversion occurred in two patients in the TEO groupTable 1
Patient characteristics.
Variable TEO (n ¼ 48) TAE (n ¼ 44) P-value
Sex
Male 32 (66.7%) 23 (51.1%)
Female 16 (33.3%) 21 (47.7%)
Age (median, range) 58 (30e85) 62 (28e85) 0.39
Preoperative diagnosis 0.239
Adenocarcinoma 15 (31.2%) 22 (50%)
Adenoma 7 (14.6%) 6 (13.6%)
NET 24 (50%) 13 (32.5%)
GIST/Melanoma 2 (4.2%) 3 (6.8%)
Surgery indications 0.015
Other 30 (62.5%) 32 (72.7%) 0.673
s/p EMR 16 (33.3%) 5 (11.4%)
s/p CRTx 2 (4.2%) 7 (15.9%) 0.10
GIST: Gastrointestinal stroma tissue tumor, NET: neuroendocrine tumor, TEO: trans-
anal endoscopic operation, TAE: trans-anal excision, other: adenocarcinoma,
carcinoid, polyps, and benign tumors, S/P: status post.(conversion from local transanal excision to exploratory laparot-
omy); however, there was no conversion in the TAE group [2 (4.2%)
vs. 0 (0%), p ¼ 0.051, respectively]. Complications in the TEO group
include bleeding (n ¼ 1, 2.1%), perianal abscess (n ¼ 1, 2.1%), and
perforation (n ¼ 3, 4.2%). Bleeding was self-limited and did not
surgical intervension, Abscess treated by incision and drainage,
whereas perforation managed by radical resection. No complica-
tions were reported for the TAE procedure (p ¼ 0.028 comparingTumor size (mean, cm) 1.6 ± 1.68 1.17 ± 1.17 0.148
T status (cancer only) N ¼ 16 N ¼ 20
No residual cancer 2 (12.5%) 5 (25%) 0.769
T1Sm1 6 (37.5%) 7 (35%)
T1Sm2 2 (12.5%) 3 (15%)
T1Sm3 2 (12.5%) 3 (15%)
T2 3 (18.8%) 2 (10%)
T3 1 (6.2%) 0 (0%)
Final pathology 0.082
No residual tumor 10 (20.8%) 1 (2.3%)
Adenocarcinoma 16 (33.3%) 20 (45.5%)
Adenoma 4 (8.3%) 7 (15.9%)
NET 16 (33.3%) 13 (29.5%)
Other (GIST/Melanoma) 2 (4.2%) 3 (6.8%)
AV: anal verge, GIST: gastrointestinal stroma tissue tumor, NET: neuroendocrine
tumor, TEO: trans-anal endoscopic operation, TAE: trans-anal excision, T1sm1: tu-
mor depth at one-third of the submucosa, T1SM2: tumor depth at second third of
the submucosa, T1SM3: tumor depth at the last third of the submucosa, other:
adenocarcinoma, carcinoid, polyps, and benign tumors, S/P: status post, LVI:
lympho-vascular invasion.
Bold values indicate that p < 0.05 is statistically signiﬁcant.
Table 3
Complications and treatments for TEO and TAE.
Variable TEO (n ¼ 48) TAE (n ¼ 44) P-value
Adjuvant therapy 0.037
No 47 (97.9%) 38 (86.4%)
Yes 1 (2.1%) - CRTx 6 (13.6%)e
3 CTx, 3 CRTx
Complication 0.028
Bleeding 1 (2.1%) 0 (0%)
Perianal abscess 1 (2.1%) 0 (0%)
Perforation 3 (4.2%) 0 (0%)
Conversion 0.051
No 46 (95.8%) 44 (100%)
Yes 2 (4.2%) e bowel
perforation
(size 6 cm, 3 cm)
0 (0%)
Salvage operation 0.039
No 41 (85.4%) 42 (97.7%)
Yes 7 (14.6%) 1 (2.3%)
CTx: chemotherapy, CRTx: chemoradiotherapy, TEO: trans-anal endoscopic opera-
tion, TAE: trans-anal excision.
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performed in seven (14.6%) TEO patients vs. one (2.3%).
TAE patient (p ¼ 0.039). Furthermore, adjuvant chemo-
radiotherapy (CRT) was administered to one (2.1%) patient in the
TEO group compared to six (13.6%) patients in the TAE group
(p ¼ 0.037). Among TAE patients, three patients received only
adjuvant chemotherapy, while three patients underwent CRT, as
shown in Table 3.
3.4. Recurrence rate and disease-free survival
Local recurrence was documented in a total of eight patients
diagnosed with adenocarcinoma, four in each operation group, as
shown in Table 4. Disease-free survival was similar in both groups:
TEO e 41.8 months, 95% RI 39.4e44.1; TAE 79.7 months, 95% RI
72.2e87.3 as shown in Fig. 3.
4. Discussion
The TEO procedure was developed to overcome the limitations
of conventional TAE. TEO is a minimally invasive technique that
utilizes a 30 camera and laparoscopic instruments to expose the
operation ﬁeld, including tumor location and tumor margin, and
can transmit the entire operation to a monitor for adequate visu-
alization and for teaching purposes. The most critical consideration
in rectal surgery is adequate resection margin, followed by good
visualization of the operative ﬁeld. If these goals are not achieved,
remnant tumor could lead to a high local recurrence rate. Research
has therefore focused on improving visualization. In the Norwegian
Rectal Cancer study [15] that compared trans-anal excision and
radical resection of stage I-III rectal cancer, rate of local recurrenceTable 4
Comparison of recurrence rates between the two techniques.
Variable TEO (n ¼ 48) TAE (n ¼ 44) P ¼ value
Recurrence rate 0.898
No 44 (91.7%) 40 (90.9%)
Yes 4 (8.3%) 4 (9.1%)
Recurrence among
cancer
Total adenoca
(16)
Total
adenoca (20)
0.720
No 12 (75%) 16 (80%)
Yes 4 (25%) 4 (20%)
Adenoca: invasive adenocarcinoma, TEO: trans-anal endoscopic operation, TAE:
trans-anal excision.was greater in the TAE group than the radical surgery group at 12%
vs. 6%, (p ¼ 0.01). Mellgren et al. [6] compared recurrence rates of
153 patients with low rectal cancer who underwent TAE and radical
resection; they reported a 9% overall recurrence for T1N0 tumors
and a 16% rate for T2N0 tumors. The high rate of overall recurrence
was due to the presence of malignancy in the regional lymph node
that must be targeted in a curative surgery. Nevertheless, colorectal
cancer submucosal invasion is associated with lymph node
metastasis in 6%e12% of cases [16,17]. Therefore, revision of
transanal excision techniques and indications is necessary to avoid
dismal prognosis. Gangping et al. [18] analyzed 116 patients with
rectal cancer who underwent transanal excision and concluded
that TAE for rectal cancer is satisfactory for T1 stage tumors, but it is
not suitable for T2 stage tumors due to the high local recurrence
rate in T2 lesions (6% vs. 15%, respectively).
Milestone improvements of the technology used in the TEO
setting have improved operative ﬁeld exposure and the feasibility
of completely excising rectal tumors in a safe manner. TEO has
achieved success in the ﬁeld of benign rectal tumors. Moreover, TEO
has become an alternative to the TME procedure in early rectal
cancer. Hur et al. [19] conﬁrmed the safety of the TEO procedure in
46 patients with rectal tumors. The TAE procedure is also safe, with
minimal trauma and no disturbance of urinary and sexual functions
[20]; however, technical obstacles and unsuitability of this tech-
nique for higher tumor levels have contributed to the demand for a
better alternative technique. In the NCCN guidelines, TAE is indi-
cated for tumors with a diameter less than 3 cm and less than one-
third of the rectum circumference. TEO procedure, however, we
were able to operate at a higher level and could excise larger tu-
mors in a well-visualized operative ﬁeld in a comfortable setting.
Conventional TAE is possible for rectal tumors <8 cm from the anal
verge whereas TEO could approach rectal tumor as high as
7.46± 3.8 cm from the anal verge, which is close to the distance that
can be obtained using the TEM technique [21,22].
Perforation is the most frequently intraoperative complication
of TEO, ranging from 2 to 30% [23,24]. Only two of our TEO patients
(4.2%) had perforation into the peritoneum. we claimed two rea-
sons of these perforation events in our series; tumor size (6 and
3 cm) and tumor set anteriorly at high level high (10 cm from anal
verge). Conversion to exploratory laparotomy was performed to
treat perforation. In addition, Morino et al. [25] studied risk factors
attributed in high rate of perforation into the peritoneum cavity
with a risk of 3.2% if the tumor was located more than 6 cm from
the anal verge or if it was located anterior and above the peritoneal
reﬂection [19].
A second important factor to consider is post-operative
bleeding. This issue has not addressed well in the literature. Few
articles correlated risk of bleeding with tumor dimensions and the
lateral position of the tumor in TEM [26,27]. In our study, no case of
post-operative bleeding was observed after the TEO procedure.
Local recurrence has not beenwidely investigated in the context
of the TEO technique, but it has been studied for TEM. Local
recurrence rate for TEM was initially high due to inclusion of cases
with tumors penetrating deep into the submucosa [range, 0e23%]
[28,29]. However, with the limited indications for trans-anal exci-
sion, the rate of local recurrence was reduced to 3% [30]. TEO or
TEM are alternative techniques for radical rectal surgery, particu-
larly for low-risk rectal tumors. Selection criteria for this treatment
include a mobile tumor, size <4 cm, favorable histology without
lymphovascular invasion, and anatomic accessibility with the
ability to achieve 1-cm circumferential margins. A prospective
randomized clinical trial comparing TEM with TME in 70 patients
who had received neoadjuvant treatment reported no signiﬁcant
differences in local recurrence rates or survival rates between the
two techniques [31]. They reported Two local recurrences (5.7%)
Fig. 3. Disease-Free Survival. DFS: disease-free survival, TEO: trans-anal endoscopic operation, TAE: trans-anal excision.
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equivalent to our results.
In our study, we posted re-excision after endoscopic mucosal
resection (EMR) in 21 (44.7%). For rectal tumors, TEO can be used to
evaluate muscle invasion, achieve full thickness excision for
appropriate local staging, and obtain an adequate margin, which
make it a better alternative than EMR (excision at the submucosa
level only).
To our knowledge, this is the ﬁrst comparative study of the TEO
and TAE procedures. Patient data were recorded in an electronic
system, minimizing the chances of incorrect or missing data. The
study was conducted in a well-developed tertiary institute by
highly trained surgeons. However, our patient sample was rela-
tively small, as we have only performed the TEO procedure for the
last 5 years and many patients prefer radical rectal surgery to local
excision. Although this is a retrospective study, data were traced
electronically, which allowed us to gather all relevant information.
Lastly, preoperative staging and appropriate tumor depth measures
are obligatory to determine the correct surgical plan and man-
agement. Commonly used staging measures are digital rectal ex-
amination, enteroscopy, and endorectal ultrasonography.5. Conclusions
Given the substantial differences in treatment options and
outcomes for early rectal cancer, the TEO procedure is safe and
feasible for excision of low- and mid-rectal tumors in an appro-
priate patient population. The TEO technique is a viable alternative
to radical resection and conventional trans-anal excision.Ethical approval
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